ZA200205479B - Novel biarylcarboxamides. - Google Patents

Novel biarylcarboxamides.

Info

Publication number: ZA200205479B
Authority: ZA; South Africa
Prior art keywords: biarylcarboxamides; novel; novel biarylcarboxamides
Prior art date: 2000-02-18

Application number

ZA200205479A

Other languages

English (en)

Inventor

Eifion Phillips

Richard Schmiesing

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-18

Filing date

2002-07-09

Publication date

2003-12-31

2002-07-09 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2003-12-31 Publication of ZA200205479B publication Critical patent/ZA200205479B/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4

ZA200205479A 2000-02-18 2002-07-09 Novel biarylcarboxamides. ZA200205479B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE0000540A SE0000540D0 (sv)	2000-02-18	2000-02-18	New compounds

Publications (1)

Publication Number	Publication Date
ZA200205479B true ZA200205479B (en)	2003-12-31

Family

ID=20278508

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200205479A ZA200205479B (en)	2000-02-18	2002-07-09	Novel biarylcarboxamides.

Country Status (34)

Country	Link
US (3)	US7001914B2 (bg)
EP (1)	EP1259508B1 (bg)
JP (1)	JP4084570B2 (bg)
KR (1)	KR100769394B1 (bg)
CN (1)	CN100345847C (bg)
AR (1)	AR029798A1 (bg)
AT (1)	ATE252099T1 (bg)
AU (1)	AU782693B2 (bg)
BG (1)	BG106977A (bg)
BR (1)	BR0108456A (bg)
CA (1)	CA2397233A1 (bg)
CO (1)	CO5280046A1 (bg)
CZ (1)	CZ20022787A3 (bg)
DE (1)	DE60100996T2 (bg)
DK (1)	DK1259508T3 (bg)
EE (1)	EE05149B1 (bg)
ES (1)	ES2208556T3 (bg)
HK (1)	HK1050007A1 (bg)
HU (1)	HUP0301069A3 (bg)
IL (1)	IL150544A0 (bg)
IS (1)	IS6492A (bg)
MX (1)	MXPA02007543A (bg)
MY (1)	MY123580A (bg)
NO (1)	NO20023917L (bg)
NZ (1)	NZ520094A (bg)
PL (1)	PL202044B1 (bg)
PT (1)	PT1259508E (bg)
RU (1)	RU2263114C2 (bg)
SE (1)	SE0000540D0 (bg)
SK (1)	SK11792002A3 (bg)
TR (1)	TR200400072T4 (bg)
UA (1)	UA73540C2 (bg)
WO (1)	WO2001060821A1 (bg)
ZA (1)	ZA200205479B (bg)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE0000540D0 (sv) *	2000-02-18	2000-02-18	Astrazeneca Ab	New compounds
AU2001284645A1 (en) *	2000-08-18	2002-03-04	Pharmacia And Upjohn Company	Quinuclidine-substituted aryl compounds for treatment of disease
US6492385B2 (en)	2000-08-18	2002-12-10	Pharmacia & Upjohn Company	Quinuclidine-substituted heteroaryl moieties for treatment of disease
US6486172B2 (en)	2000-08-18	2002-11-26	Pharmacia & Upjohn Company	Quinuclidine-substituted aryl compounds for treatment of disease
WO2002016358A2 (en) *	2000-08-18	2002-02-28	Pharmacia & Upjohn Company	Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
AU2001284646A1 (en) *	2000-08-21	2002-03-04	Pharmacia And Upjohn Company	Quinuclidine-substituted heteroaryl moieties for treatment of disease
AU2001282875A1 (en) *	2000-08-21	2002-03-04	Pharmacia And Upjohn Company	Quinuclidine-substituted heteroaryl moieties for treatment of disease
JP2004506734A (ja) *	2000-08-21	2004-03-04	ファルマシア・アンド・アップジョン・カンパニー	疾患治療用のキヌクリド置換ヘテロアリール部分
PE20021019A1 (es) *	2001-04-19	2002-11-13	Upjohn Co	Grupos azabiciclicos sustituidos
AR036040A1 (es)	2001-06-12	2004-08-04	Upjohn Co	Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
AR036041A1 (es)	2001-06-12	2004-08-04	Upjohn Co	Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen
WO2003018585A1 (en)	2001-08-24	2003-03-06	Pharmacia & Upjohn Company	Substituted-heteroaryl-7-aza[2.2.1]bicycloheptanes for the treatment of disease
CA2460075A1 (en) *	2001-09-12	2003-03-20	Donn Gregory Wishka	Substituted 7-aza[2.2.1] bicycloheptanes for the treatment of diseases
KR100614900B1 (ko)	2001-10-02	2006-08-25	파마시아 앤드 업존 캄파니 엘엘씨	질병의 치료를 위한 아자비시클릭-치환된 융합-헤테로아릴화합물
EP1453828A2 (en) *	2001-10-16	2004-09-08	AstraZeneca AB	Azabicyclic compounds for the treatment of fibromyalgia syndrome
US6849620B2 (en)	2001-10-26	2005-02-01	Pfizer Inc	N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease
JP2005511574A (ja) *	2001-10-26	2005-04-28	ファルマシアアンドアップジョンカンパニーリミティドライアビリティーカンパニー	Ｎａｃｈｒアゴニストとしてのｎ−アザビシクロ−置換ヘテロ二環式カルボキサミド
WO2003040147A1 (en) *	2001-11-08	2003-05-15	Pharmacia & Upjohn Company	Azabicyclic-substituted-heteroaryl compounds for the treatment of disease__________________________________________________________________________________________________________________________
JP2005510523A (ja)	2001-11-09	2005-04-21	ファルマシアアンドアップジョンカンパニーリミティドライアビリティーカンパニー	アザ二環式フェニル縮合複素環式化合物、及びα７ＮＡＣＨＲリガンドとしての当該化合物の使用
DE10156719A1 (de) *	2001-11-19	2003-05-28	Bayer Ag	Heteroarylcarbonsäureamide
DE10162375A1 (de)	2001-12-19	2003-07-10	Bayer Ag	Bicyclische N-Aryl-amide
DE10164139A1 (de)	2001-12-27	2003-07-10	Bayer Ag	2-Heteroarylcarbonsäureamide
US6852716B2 (en)	2002-02-15	2005-02-08	Pfizer Inc	Substituted-aryl compounds for treatment of disease
EP1476448A2 (en)	2002-02-19	2004-11-17	PHARMACIA & UPJOHN COMPANY	Azabicyclic compounds for the treatment of disease
CA2476681A1 (en)	2002-02-19	2003-08-28	Bruce N. Rogers	Fused bicyclic-n-bridged-heteroaromatic carboxamides for the treatment of disease
DE10211415A1 (de) *	2002-03-15	2003-09-25	Bayer Ag	Bicyclische N-Biarylamide
DE10211416A1 (de)	2002-03-15	2003-09-25	Bayer Ag	Essig- und Propionsäureamide
MXPA04012439A (es) *	2002-06-10	2005-04-19	Bayer Healthcare Ag	Amidas de acidos 2-heteroarilcarboxilicos.
JP2005537297A (ja)	2002-08-01	2005-12-08	ファルマシア・アンド・アップジョン・カンパニー・エルエルシー	アルファ−７ｎａｃｈｒ活性を有する１ｈ−ピラゾールおよび１ｈ−ピロール−アザビシクロ化合物
GB0220581D0 (en) *	2002-09-04	2002-10-09	Novartis Ag	Organic Compound
CA2508004A1 (en) *	2002-12-11	2004-06-24	Pharmacia & Upjohn Company Llc	Treatment of diseases with combinations of alpha 7 nicotinic acetylcholine receptor agonists and other compounds
KR20050092777A (ko) *	2003-01-22	2005-09-22	파마시아 앤드 업존 캄파니 엘엘씨	알파-7 ｎＡＣｈ 수용체 전체 작용물질을 사용하는 질병의치료
GB0310867D0 (en) *	2003-05-12	2003-06-18	Novartis Ag	Organic compounds
WO2005000250A2 (en) *	2003-06-24	2005-01-06	Johns Hopkins University	Imaging agents and methods of imaging alpha 7-nicotinic cholinergic receptor
DE10334724A1 (de) *	2003-07-30	2005-02-24	Bayer Healthcare Ag	N-Biarylamide
CA2550847A1 (en) *	2003-12-22	2005-07-07	Glen Ernst	Nicotinic acetylcholine receptor ligands
CA2550844A1 (en) *	2003-12-22	2005-07-07	Glen Ernst	Nicotinic acetylcholine receptor ligands
PE20060437A1 (es)	2004-06-18	2006-06-08	Novartis Ag	COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR
GB0415746D0 (en)	2004-07-14	2004-08-18	Novartis Ag	Organic compounds
GB0424564D0 (en)	2004-11-05	2004-12-08	Novartis Ag	Organic compounds
EP1910328A1 (en) *	2005-06-29	2008-04-16	AstraZeneca AB	Thiophene-2-carboxamide derivatives as alpha 7 nicotinic receptor modulators
GB0521508D0 (en)	2005-10-21	2005-11-30	Novartis Ag	Organic compounds
GB0525673D0 (en) *	2005-12-16	2006-01-25	Novartis Ag	Organic compounds
GB0525672D0 (en)	2005-12-16	2006-01-25	Novartis Ag	Organic compounds
ES2569660T3 (es)	2007-06-08	2016-05-12	Mannkind Corporation	Inhibidores de la IRE-1alfa
TW200911808A (en) *	2007-07-23	2009-03-16	Astrazeneca Ab	Novel compounds
SA08290475B1 (ar)	2007-08-02	2013-06-22	Targacept Inc	(2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
TW201031664A (en)	2009-01-26	2010-09-01	Targacept Inc	Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
IN2012DN02968A (bg)	2009-10-13	2015-07-31	Msd Oss Bv
ES2649539T3 (es)	2010-05-17	2018-01-12	Forum Pharmaceuticals Inc.	Formulaciones farmacéuticas que comprenden formas cristalinas de clorhidrato de (R)-7-cloro-N-(quinuclidin-3-il)benzo(b)tiofeno-2-carboxamida monohidratado
KR101928505B1 (ko)	2011-01-28	2018-12-12	에스케이바이오팜 주식회사	피리돈 유도체 및 이를 포함하는 약학적 조성물
KR101925971B1 (ko) *	2011-01-28	2018-12-06	에스케이바이오팜 주식회사	피리돈 유도체 및 이를 포함하는 약학적 조성물
GB201111705D0 (en)	2011-07-07	2011-08-24	Takeda Pharmaceutical	Compounds and their use
GB201111704D0 (en)	2011-07-07	2011-08-24	Takeda Pharmaceutical	Novel compounds
WO2013010679A1 (en)	2011-07-15	2013-01-24	Novartis Ag	Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursors
JO3115B1 (ar)	2011-08-22	2017-09-20	Takeda Pharmaceuticals Co	مركبات بيريدازينون واستخدامها كمثبطات daao
EP2846796A4 (en)	2012-05-08	2015-10-21	Forum Pharmaceuticals Inc	METHODS OF MAINTAINING, PROCESSING OR ENHANCING COGNITIVE FUNCTION
GB201209587D0 (en)	2012-05-30	2012-07-11	Takeda Pharmaceutical	Therapeutic compounds
US9593106B2 (en)	2013-02-07	2017-03-14	Heptares Therapeutics Limited	Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic M4 receptor agonists
EA029430B1 (ru)	2013-06-21	2018-03-30	Такеда Фармасьютикл Компани Лимитед	Производные 1-сульфонилпиперидина в качестве модуляторов рецепторов прокинетицина
GB201314286D0 (en)	2013-08-08	2013-09-25	Takeda Pharmaceutical	Therapeutic Compounds
GB201318222D0 (en)	2013-10-15	2013-11-27	Takeda Pharmaceutical	Novel compounds
GB201320905D0 (en)	2013-11-27	2014-01-08	Takeda Pharmaceutical	Therapeutic compounds
FI20145054L (fi) *	2014-01-21	2015-07-22	Tellabs Oy	Tiedonsiirtoverkon verkkoelementti
TW201613864A (en)	2014-02-20	2016-04-16	Takeda Pharmaceutical	Novel compounds
KR101623138B1 (ko)	2014-10-28	2016-05-20	한국원자력연구원	베타 아밀로이드 플라크 검출 및 알츠하이머 질환 진단 또는 치료용 조성물
GB201616839D0 (en)	2016-10-04	2016-11-16	Takeda Pharmaceutical Company Limited	Therapeutic compounds
GB201619514D0 (en)	2016-11-18	2017-01-04	Takeda Pharmaceuticals Co	Novel compounds
JP2021138648A (ja)	2020-03-04	2021-09-16	武田薬品工業株式会社	経口固形製剤

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1416872A (en) *	1972-03-10	1975-12-10	Wyeth John & Brother Ltd	4-aminoquinoline derivatives
FI791491A (fi) *	1979-05-10	1980-11-11	Kopo Konepohja Oy	Traebitshugg
FR2529548A1 (fr)	1982-07-02	1984-01-06	Delalande Sa	Nouveaux derives de l'amino-3 quinuclidine, leur procede et leur application en therapeutique
US4605652A (en) *	1985-02-04	1986-08-12	A. H. Robins Company, Inc.	Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes
US4863919A (en) *	1988-02-01	1989-09-05	A. H. Robins Company, Incorporated	Method of enhancing memory or correcting memory deficiency with arylamido(and arylthiomido)-azabicycloalkanes
CA2090037A1 (en) *	1990-08-31	1992-03-01	Shoichi Chokai	Indole derivatives and drugs
JPH04247081A (ja) *	1991-02-01	1992-09-03	Takeda Chem Ind Ltd	５員複素環酸アミド類
SE9904176D0 (sv)	1999-11-18	1999-11-18	Astra Ab	New use
SE0000540D0 (sv) *	2000-02-18	2000-02-18	Astrazeneca Ab	New compounds
FR2809730B1 (fr)	2000-05-31	2002-07-19	Sanofi Synthelabo	Derives de 1,4-diazabicyclo[3.2.2] nonanebenzoxazole, -benzothiazole et -benzimidazole, leur preparation et leur application therapeutique
FR2809731B1 (fr)	2000-05-31	2002-07-19	Sanofi Synthelabo	Derives de 1,4-diazabicyclo-[3.2.2] nonane-pheylisoxazole, leur preparation et leur application en therapeutique
FR2809732B1 (fr)	2000-05-31	2002-07-19	Sanofi Synthelabo	DERIVES DE 4(-2-PHENYLTHIAZOL-5-yl)-1,4-DIAZABICYCLO-[3.2.2] NONANE, LEUR PREPARATION ET LEUR APPLICATION ENTHERAPEUTIQUE
TW593223B (en)	2000-06-20	2004-06-21	Merz Pharma Gmbh & Co Kgaa	1-amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists
AU2001284645A1 (en)	2000-08-18	2002-03-04	Pharmacia And Upjohn Company	Quinuclidine-substituted aryl compounds for treatment of disease
US6492385B2 (en) *	2000-08-18	2002-12-10	Pharmacia & Upjohn Company	Quinuclidine-substituted heteroaryl moieties for treatment of disease
US6486172B2 (en)	2000-08-18	2002-11-26	Pharmacia & Upjohn Company	Quinuclidine-substituted aryl compounds for treatment of disease
WO2002016358A2 (en)	2000-08-18	2002-02-28	Pharmacia & Upjohn Company	Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
JP2004506734A (ja)	2000-08-21	2004-03-04	ファルマシア・アンド・アップジョン・カンパニー	疾患治療用のキヌクリド置換ヘテロアリール部分
AU2001282875A1 (en)	2000-08-21	2002-03-04	Pharmacia And Upjohn Company	Quinuclidine-substituted heteroaryl moieties for treatment of disease
AU2001284646A1 (en)	2000-08-21	2002-03-04	Pharmacia And Upjohn Company	Quinuclidine-substituted heteroaryl moieties for treatment of disease
DE10045112A1 (de)	2000-09-11	2002-03-21	Merck Patent Gmbh	Verwendung von Indolderivaten zur Behandlung von Erkrankungen des zentralen Nervensystems
ATE385497T1 (de)	2000-12-01	2008-02-15	Neurosearch As	3-substituierte quinuclidin-derivate und deren verwendung als nikotinischen agonisten
US20020086871A1 (en)	2000-12-29	2002-07-04	O'neill Brian Thomas	Pharmaceutical composition for the treatment of CNS and other disorders
CA2550847A1 (en) *	2003-12-22	2005-07-07	Glen Ernst	Nicotinic acetylcholine receptor ligands
US7396830B2 (en) *	2005-10-04	2008-07-08	Bristol-Myers Squibb Company	Piperazine amidines as antiviral agents

2000
- 2000-02-18 SE SE0000540A patent/SE0000540D0/xx unknown
2001
- 2001-02-12 AR ARP010100628A patent/AR029798A1/es unknown
- 2001-02-15 RU RU2002118302/04A patent/RU2263114C2/ru active
- 2001-02-15 CZ CZ20022787A patent/CZ20022787A3/cs unknown
- 2001-02-15 AT AT01904770T patent/ATE252099T1/de not_active IP Right Cessation
- 2001-02-15 IL IL15054401A patent/IL150544A0/xx unknown
- 2001-02-15 HU HU0301069A patent/HUP0301069A3/hu unknown
- 2001-02-15 WO PCT/SE2001/000329 patent/WO2001060821A1/en active IP Right Grant
- 2001-02-15 ES ES01904770T patent/ES2208556T3/es not_active Expired - Lifetime
- 2001-02-15 BR BR0108456-9A patent/BR0108456A/pt not_active Application Discontinuation
- 2001-02-15 CN CNB018049362A patent/CN100345847C/zh not_active Expired - Fee Related
- 2001-02-15 CA CA002397233A patent/CA2397233A1/en not_active Abandoned
- 2001-02-15 AU AU32594/01A patent/AU782693B2/en not_active Ceased
- 2001-02-15 JP JP2001560205A patent/JP4084570B2/ja not_active Expired - Fee Related
- 2001-02-15 EP EP01904770A patent/EP1259508B1/en not_active Expired - Lifetime
- 2001-02-15 PL PL357565A patent/PL202044B1/pl not_active IP Right Cessation
- 2001-02-15 TR TR2004/00072T patent/TR200400072T4/xx unknown
- 2001-02-15 DE DE60100996T patent/DE60100996T2/de not_active Expired - Fee Related
- 2001-02-15 NZ NZ520094A patent/NZ520094A/en unknown
- 2001-02-15 DK DK01904770T patent/DK1259508T3/da active
- 2001-02-15 PT PT01904770T patent/PT1259508E/pt unknown
- 2001-02-15 MX MXPA02007543A patent/MXPA02007543A/es active IP Right Grant
- 2001-02-15 SK SK1179-2002A patent/SK11792002A3/sk unknown
- 2001-02-15 EE EEP200200459A patent/EE05149B1/xx not_active IP Right Cessation
- 2001-02-15 KR KR1020027010731A patent/KR100769394B1/ko not_active IP Right Cessation
- 2001-02-15 UA UA2002075475A patent/UA73540C2/uk unknown
- 2001-02-16 CO CO01012482A patent/CO5280046A1/es not_active Application Discontinuation
- 2001-02-16 MY MYPI20010711A patent/MY123580A/en unknown
2002
- 2002-04-15 US US10/123,856 patent/US7001914B2/en not_active Expired - Fee Related
- 2002-07-09 ZA ZA200205479A patent/ZA200205479B/xx unknown
- 2002-08-02 BG BG106977A patent/BG106977A/bg unknown
- 2002-08-08 IS IS6492A patent/IS6492A/is unknown
- 2002-08-16 NO NO20023917A patent/NO20023917L/no not_active Application Discontinuation
2003
- 2003-03-28 HK HK03102250A patent/HK1050007A1/xx not_active IP Right Cessation
2006
- 2006-01-05 US US11/325,787 patent/US7214688B2/en not_active Expired - Fee Related
2007
- 2007-03-01 US US11/680,930 patent/US7491734B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CO5280046A1 (es)	2003-05-30
CN1400973A (zh)	2003-03-05
RU2263114C2 (ru)	2005-10-27
ES2208556T3 (es)	2004-06-16
US20070149563A1 (en)	2007-06-28
IS6492A (is)	2002-08-08
EP1259508A1 (en)	2002-11-27
BR0108456A (pt)	2003-04-01
PT1259508E (pt)	2004-03-31
MY123580A (en)	2006-06-30
DE60100996D1 (de)	2003-11-20
KR100769394B1 (ko)	2007-10-22
MXPA02007543A (es)	2002-12-13
SE0000540D0 (sv)	2000-02-18
IL150544A0 (en)	2003-02-12
HK1050007A1 (en)	2003-06-06
EE05149B1 (et)	2009-04-15
US20060128749A1 (en)	2006-06-15
US20030008867A1 (en)	2003-01-09
US7214688B2 (en)	2007-05-08
US7001914B2 (en)	2006-02-21
NZ520094A (en)	2005-01-28
CA2397233A1 (en)	2001-08-23
TR200400072T4 (tr)	2004-02-23
KR20020072585A (ko)	2002-09-16
HUP0301069A2 (hu)	2003-08-28
SK11792002A3 (sk)	2003-04-01
CZ20022787A3 (cs)	2003-02-12
NO20023917L (no)	2002-09-16
US7491734B2 (en)	2009-02-17
AU3259401A (en)	2001-08-27
ATE252099T1 (de)	2003-11-15
CN100345847C (zh)	2007-10-31
JP2003523342A (ja)	2003-08-05
NO20023917D0 (no)	2002-08-16
JP4084570B2 (ja)	2008-04-30
PL357565A1 (en)	2004-07-26
AR029798A1 (es)	2003-07-16
AU782693B2 (en)	2005-08-18
BG106977A (bg)	2003-05-30
EE200200459A (et)	2003-12-15
DK1259508T3 (da)	2004-02-16
PL202044B1 (pl)	2009-05-29
EP1259508B1 (en)	2003-10-15
HUP0301069A3 (en)	2004-09-28
DE60100996T2 (de)	2004-09-02
UA73540C2 (en)	2005-08-15
WO2001060821A1 (en)	2001-08-23

Publication	Publication Date	Title
ZA200205479B (en)	2003-12-31	Novel biarylcarboxamides.
MXPA03002410A (es)	2003-06-19	4-amino-quinazolinas.
MXPA03005445A (es)	2003-09-10	Barra colectora 12c para aislar los circuitos integrados seleccionados para una comunicacion rapida de barra colectora 12c.
AU8860401A (en)	2002-03-13	Novel guanidinobenzamides
ZA200208561B (en)	2003-05-19	Hydraulischer druckverstarker.
ZA200007669B (en)	2001-07-13	Insert.
EG23262A (en)	2004-10-31	Delta -pyrrolines.
MXPA01009037A (es)	2003-11-18	I-bet.
HK1055426A1 (en)	2004-01-09	Indoloquinazolinones.
MXPA03001877A (es)	2003-06-24	2-guanidin-4-arilquinazolinas.
MXPA03001591A (es)	2003-09-10	Derivados y analogos de 10-aril-11-h-benzo(b) fluorena para uso medicinal.
MXPA03008139A (es)	2003-12-12	Fluoralcoxifenilsulfonilureas sustituidas.
ZA200205389B (en)	2003-03-12	Booklet.
MXPA03002668A (es)	2003-08-20	Guanidinas de sulfonilo.
MXPA03001991A (es)	2003-06-24	Novedosas arilalcano-sulfonamidas.
MXPA03005714A (es)	2003-10-06	Sulfamidotienopirimidinas.
MXPA03002411A (es)	2003-06-19	4-amino-quinazolinas.
AU8197001A (en)	2002-02-05	Novel arylethene-sulfonamides
MXPA03005494A (es)	2003-10-06	Benzoilpiridazinas.
MXPA01011743A (es)	2003-09-05	Arilpirimidinas substituidas 5-.
HK1061560A1 (en)	2004-09-24	Triazolo-epothilones.
MXPA01000464A (es)	2003-07-21	Composicion.
MXPA02000261A (es)	2003-08-20	Aminoindanos novedosos.
GB0002612D0 (en)	2000-03-29	C.m.e
HK1039800A1 (en)	2002-05-10	Stay.